Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Breast Neoplasms and PTPN2[original query] |
|---|
| Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer. Breast cancer research and treatment 2015 Aug 153 (1): 31-40. Karlsson Elin, Veenstra Cynthia, Emin Shad, Dutta Chhanda, Pérez-Tenorio Gizeh, Nordenskjöld Bo, Fornander Tommy, Stål Ol |
| PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer. Journal of cancer research and clinical oncology 2019 Mar 145 (3): 599-607. Karlsson Elin, Veenstra Cynthia, Gårsjö Jon, Nordenskjöld Bo, Fornander Tommy, Stål Ol |
| ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab. Oncology letters 2019 3 17 (3): 3371-3381. Ellegård Sander, Veenstra Cynthia, Pérez-Tenorio Gizeh, Fagerström Victor, Gårsjö Jon, Gert Krista, Sundquist Marie, Malmström Annika, Wingren Sten, Elander Nils O, Hallbeck Anna-Lotta, Stål Ol |
- Page last reviewed:Feb 1, 2024
- Content source:

